therascreen FGFR RGQ RT-PCR kit (US IVD) REF 874721

FDA Device Recall #Z-1650-2022 — Class II — July 20, 2022

Recall Summary

Recall Number Z-1650-2022
Classification Class II — Moderate risk
Date Initiated July 20, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Qiagen Sciences LLC
Location Germantown, MD
Product Type Devices
Quantity 22 kits

Product Description

therascreen FGFR RGQ RT-PCR kit (US IVD) REF 874721

Reason for Recall

Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects

Distribution Pattern

IN, NC, MN, TX Foreign: Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, Thailand

Lot / Code Information

Lot number: 172017274 Exp Date: 10.11.2022 169046366 Exp. Date: 12.06.2022

Other Recalls from Qiagen Sciences LLC

Recall # Classification Product Date
Z-1504-2025 Class II Brand Name: QIAstat-Dx Product Name: QIAstat-D... Mar 12, 2025
Z-2353-2024 Class II QIAcube Connect MDx - IVD Instrument designed t... Jun 3, 2024
Z-1508-2024 Class II EZ2 Connect MDx-IVD Designed to perform automat... Mar 4, 2024
Z-1683-2023 Class II QIAstat-Dx Respiratory SARS-CoV-2 Panel multipl... Apr 28, 2023
Z-1652-2022 Class II FGFR RGQ RT-PCR Kit (RUO, not IVD) REF 8747010 Jul 20, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.